{"id":"W4282018957","doi":"10.1200/jco.2022.40.16_suppl.7548","title":"Clinical and patient (pt)-reported outcomes (PROs) in a phase 3, randomized, open-label study evaluating axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in elderly pts with relapsed/refractory (R/R) large B-cell lymphoma (LBCL; ZUMA-7).","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Phases of clinical research; Chemoimmunotherapy; Adverse effect; Refractory (planetary science); Oncology; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003588845,0.001432328,0.001578629,0.0003725303,0.0003611099,0.0008372985,0.000770313,0.001333433,0.004068561],"category_scores_gemma":[0.002173404,0.0004864211,0.002626944,0.0004345133,0.0008947077,0.0008825235,0.0006133845,0.002328323,0.000511976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009550046,"about_ca_system_score_gemma":0.0009729295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006139392,"about_ca_topic_score_gemma":0.001575217,"domain_scores_codex":[0.998406,0.001075177,0.00007963903,0.000176868,0.0001107437,0.0001516125],"domain_scores_gemma":[0.9980987,0.0004950195,0.0006618198,0.0001160071,0.00009334619,0.0005351306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9801119,0.006524582,0.002951332,0.0002334796,0.001195885,0.00002313168,0.00003188774,0.0004061818,0.001402404,0.00003985165,0.0003022079,0.006777262],"study_design_scores_gemma":[0.7265476,0.2501394,0.01887974,0.00003687202,0.00177043,0.00005642348,0.0000450139,0.001075312,0.0006616675,0.0001348477,0.0006284894,0.00002421521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952825,0.001244082,0.0002334736,0.0001733786,0.00008396758,0.001333258,0.0009389051,0.00001907342,0.0006913882],"genre_scores_gemma":[0.9944797,0.0004986097,0.0005901371,0.0003738667,0.0001526461,0.002406257,0.0009331305,0.000007007143,0.0005586199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004068561,"threshold_uncertainty_score":0.01897985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2142695218919488,"score_gpt":0.5364124915908745,"score_spread":0.3221429696989256,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}